How do you take radiotherapy to the next level?How are ValiRx developing personalised medicines for the treatment of cancer? “Can cancer cells become “normal”? Introducing Rosalind, the ultimate personalised cancer treatment.” Breakthrough technology for bladder cancer succeeds in Phase II Is Abzena the new force in building better biopharmaceuticals? Can Immunaid really “turn-off” cancer? Is TxCell close to delivering affordable personalised therapies for chronic autoimmune inflammatory diseases? Harnessing J&J's Power to turn early stage science into patient solutions Pfizer explains their R&D Partnership Strategy Zoetis, a world leader in animal health Fighting Prostate Cancer with The MIL-38 MiStatTM in vitro diagnostic test: Brad Walsh, CEO, Minomic Changing the rules of the game. Steve Bates, CEO, BIA The Importance of Funding Early Innovation. Roel Bulthuis, Head of MS Ventures.